000 01514 a2200481 4500
005 20250516202943.0
264 0 _c20141215
008 201412s 0 0 eng d
022 _a1532-1827
024 7 _a10.1038/bjc.2014.129
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlvarez, R
245 0 0 _aReply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.
_h[electronic resource]
260 _bBritish journal of cancer
_cOct 2014
300 _a1677-8 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aFibroblasts
_xpathology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
700 1 _aMusteanu, M
700 1 _aGarcia-Garcia, E
700 1 _aLopez-Casas, P P
700 1 _aMegias, D
700 1 _aGuerra, C
700 1 _aMuñoz, M
700 1 _aQuijano, Y
700 1 _aCubillo, A
700 1 _aRodriguez-Pascual, J
700 1 _aPlaza, C
700 1 _ade Vicente, E
700 1 _aPrados, S
700 1 _aTabernero, S
700 1 _aBarbacid, M
700 1 _aLopez-Rios, F
700 1 _aHidalgo, M
773 0 _tBritish journal of cancer
_gvol. 111
_gno. 8
_gp. 1677-8
856 4 0 _uhttps://doi.org/10.1038/bjc.2014.129
_zAvailable from publisher's website
999 _c23652583
_d23652583